MCL

Clinical trials for MCL explained in plain language.

Never miss a new study

Get alerted when new MCL trials appear

Sign up with your email to follow new studies for MCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 2

New hope for Tough-to-Treat blood cancer patients

Disease control Recruiting now

This study is testing whether a combination of two drugs, glofitamab and lenalidomide, can help control a hard-to-treat type of blood cancer called mantle cell lymphoma. It is for patients whose cancer has come back or stopped responding to previous treatments, including a specif…

Matched conditions: MCL

Phase: PHASE2 • Sponsor: Peking University Third Hospital • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

MCL

Get alerted when new MCL trials appear

New hope for Tough-to-Treat blood cancer patients